- Low
- 66,686
- Average
- 98,781
- Median
- 89,000
- High
- 150,000
Alder Biopharmaceuticals Salary
84
41
89
Alder Biopharmaceuticals average salary is $98,781, median salary is $89,000 with a salary range from $66,686 to $150,000.
Alder Biopharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Alder Biopharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Alder Biopharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Alder Biopharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Related Alder Biopharmaceuticals Salary
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Alder Biopharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
Alder Biopharmaceuticals Jobs
| See more Alder Biopharmaceuticals Jobs» | |
| Search All Jobs | |
Alder Biopharmaceutica... Information
- Alder Biopharmaceuticals Inc
- Industry: BioTech/Drugs
- City: Bothell, WA
- Founded in January 2004, Alder Biopharmaceuticals uniquely identifies, develops, and manufactures novel antibody therapeutics to alleviate human suffering in the autoimmune and inflammatory disease areas. Alder's management team combines decades of industry experience with a proven track record for identifying and developing novel antibody therapeutics. The company acquired early funding from the United States Army in June of 2004 to explore the development of new production technologies for humanized antibodies. That early success was followed by seed funding from WRF Capital and other private investors in the Fall of 2004. Today the company is actively engaged in developing its own
